Skip to main content

Peer Review reports

From: Diverse mechanisms activate the PI 3-kinase/mTOR pathway in melanomas: implications for the use of PI 3-kinase inhibitors to overcome resistance to inhibitors of BRAF and MEK

Original Submission
10 Sep 2020 Submitted Original manuscript
3 Dec 2020 Author responded Author comments - Khanh B Tran
15 Oct 2020 Reviewed Reviewer Report - Heike Niessner
19 Nov 2020 Reviewed Reviewer Report
Resubmission - Version 2
3 Dec 2020 Submitted Manuscript version 2
18 Jan 2021 Author responded Author comments - Khanh B Tran
4 Dec 2020 Reviewed Reviewer Report - Heike Niessner
4 Jan 2021 Reviewed Reviewer Report
Resubmission - Version 3
18 Jan 2021 Submitted Manuscript version 3
Publishing
20 Jan 2021 Editorially accepted
6 Feb 2021 Article published 10.1186/s12885-021-07826-4

You can find further information about peer review here.

Back to article page
\